Numinus Wellness Inc NUMIF

Buzz on the Bullboards: Stocks to watch in volatile times.

[Jonathon Brown]

The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace. read article.

[Investor10X]

Good Luck!  I hope what ever decision you make works out well for you.  

[Investor10X]

Given the financial difficulties of the company, I'm wondering if the company still has an accountant to complete the financial statements.  Hence the delay and the MCTO.  If that's

[wealth100]

Correct me if I am wrong but they now have zero clinics and seem to be on a differnet path with the business plan. I can't figure out where the revenue stream will be coming from with all the data

[Investor10X]

The MCTO is not great, but it doesn't affect the stock in its ability to trade as it normally would, so as long as management can sort out the delay in the release of their financials.  If

[Investor10X]

It should be obvious as to why MDMA is going up.  In only a few months they have signed agreements with a number of high profile hospitals and universities (John Hopkins, Mt. Sinai, Harvard, Yale

[Larder111]

Why is numi and mdma volume and price trajectory going through the roof???Sure seems like something big is brewing behind the seen!?!?

[skeena]

Could it be that because Elon Musk has aligned himself with Trump and he's a supporter of psychedelic therapy  and that he might influence Trump to get that moving?  It makes a bit of

[wealth100]

It seems like something is going on behind the scenes.  No news yet.

[Traderstock101]

https://numinus.com/learn/news/ https://numinus.com/learn/events/

[Traderstock101]

  Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results   2024-07-11 16:30 ET - News Release   Numinus Wellness Inc. Announces Third Quarter Fiscal 2024 Results

[Traderstock101]

https://www.stockwatch.com/News/Sedardoc/5688241.pdf

[Traderstock101]

https://www.stockwatch.com/News/Sedardoc/5688228.pdf

[PressRelease]

Q3 Fiscal 2024 HighlightsRevenue of $4.3 million, a 1.9% decline over Q2 2024Gross profit of $1.0 million, a 9.8% decline over Q2 2024Cash position of $3.7 million as of May 31, 2024Transitioned out of Canadian clinical operations through an agreement with the Canadian Centre for Psychedelic...read article.

[Traderstock101]

News Release Mr. Craig MacPhail reports NUMINUS TO HOST Q3 FISCAL 2024 RESULTS CONFERENCE CALL ON JULY 11, 2024 Numinus Wellness Inc. will release its financial results for the quarter ended May

[PressRelease]

VANCOUVER, BC, July 10, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioural health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, will...read article.